Heteromeric LGP2-MDA5 receptor complexes drive antiviral signaling

When a virus invades a human cell, it leaves behind a trail of genetic debris: long strands of double-stranded RNA. The human body has a sophisticated early-warning system designed to spot this specific debris and sound the alarm. This alarm is triggered by a family of proteins called RIG-I-like receptors, which act as sentinels in the cell's cytoplasm. Two of these sentinels, MDA5 and RIG-I, are the primary detectors; when they grab onto viral RNA, they link up with other proteins to launch a massive immune response, flooding the body with signals that fight the infection. A third member of this family, LGP2, has long puzzled scientists. Unlike its cousins, LGP2 lacks the specific tools needed to send the alarm signal itself. For years, researchers wondered if LGP2 was merely a passive helper, perhaps just grabbing the viral RNA and handing it off to MDA5 before letting go, or if it played a more active, permanent role in the defense mechanism.

A team of researchers at Yale University has now settled this question, revealing that LGP2 is far more than a temporary helper. Through a series of detailed experiments, they discovered that LGP2 does not just recruit MDA5 to the viral RNA and then step aside. Instead, LGP2 becomes a permanent, integral part of the defense structure itself. The study shows that LGP2 physically locks onto the viral RNA and stays there, forming a stable, mixed complex with MDA5. This partnership does more than just bring the proteins together; it fundamentally changes the architecture of the defense line. By staying bound, LGP2 stabilizes the entire assembly, making it much harder for the viral RNA to shake off the immune proteins. Furthermore, the presence of LGP2 allows the immune system to form a functional defense line with fewer MDA5 molecules than would otherwise be required, effectively lowering the threshold needed to trigger a full-scale immune response.

The researchers began by testing how these proteins behave inside living cells. They set up a system where they could watch the immune response light up when MDA5 detected viral RNA. When they added LGP2 to the mix, the immune signal grew significantly stronger, but only if the amount of LGP2 was carefully balanced. Too much LGP2 actually blocked the signal, suggesting that the two proteins compete for space on the RNA strand. To understand why LGP2 was so much more effective than a simple substitute, the team created a version of MDA5 that lacked its signaling tools. Even though this defective MDA5 could still bind to RNA, it could not boost the immune response the way LGP2 did. This proved that LGP2 brings a unique function to the table that a standard MDA5 protein cannot replicate, even when that MDA5 is stripped of its signaling parts.

To see exactly how these proteins interact, the scientists moved from living cells to a controlled laboratory setting. They mixed purified proteins with strands of synthetic RNA and watched how they assembled. Using a technique that tracks the movement of molecules in a gel, they observed that LGP2 and MDA5 could bind to the same piece of RNA at the same time, forming a single, larger complex. They tested this with RNA strands of different lengths and found that this partnership only formed on longer strands, which are the kind typically associated with viral infections. Crucially, they showed that the order in which the proteins arrived did not matter; whether LGP2 arrived first or MDA5 did, they eventually settled into a stable, mixed structure. This confirmed that LGP2 is not just a fleeting recruiter but a structural component that remains bound throughout the process.

The team then used a highly sensitive method called mass photometry to weigh these molecular complexes individually. This allowed them to count exactly how many protein molecules were sitting on each strand of RNA. They found that without LGP2, MDA5 proteins formed long, crowded filaments, often requiring ten or more molecules to create a stable structure. However, when LGP2 was present, the filaments changed. The most stable structures formed with fewer MDA5 molecules—often just six or seven—because LGP2 was occupying a spot on the RNA and helping to hold the others in place. In fact, the researchers calculated that the presence of LGP2 reduced the number of MDA5 molecules needed to build a stable filament by nearly half. This means the immune system can react faster and more efficiently, as it does not need to wait for a large crowd of MDA5 proteins to gather before sounding the alarm.

Stability was another key factor the researchers investigated. They watched how long these protein filaments stayed intact over time. Without LGP2, the MDA5 filaments tended to fall apart relatively quickly. But when LGP2 was part of the complex, the filaments held together much longer, resisting disassembly. The researchers measured that the rate at which the filaments fell apart was cut in half when LGP2 was present. This increased stability ensures that once the immune system is triggered, the signal remains strong and persistent, giving the body enough time to mount a full defense.

Finally, the team wanted to know what part of LGP2 was responsible for this tight grip. They focused on a small, flexible tail at the end of the LGP2 protein. By cutting off this tail, they created a mutant version of the protein that could still bind to RNA but could no longer talk to MDA5. When they tested this mutant, it failed to form the stable mixed complexes. The mutant LGP2 could not help MDA5 build a filament, and in living cells, it failed to boost the immune response. In fact, without this tail, the mutant protein actually got in the way, blocking MDA5 from doing its job. This confirmed that the tail acts as a critical bridge, physically connecting LGP2 to MDA5 and locking them together on the viral RNA.

These findings reshape our understanding of how the body detects viral infections. LGP2 is not a passive bystander or a simple delivery service; it is a co-pilot that stays in the cockpit, helping to stabilize the defense structure and making the immune response more sensitive. By forming a permanent partnership with MDA5, LGP2 ensures that the body can detect and react to viral threats with greater speed and reliability. This detailed view of how these proteins work together provides a clearer picture of the molecular mechanics behind our innate immunity, offering a more complete understanding of how we defend ourselves against the constant barrage of viral invaders.